These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 27028317)

  • 1. Role of ammonia, inflammation, and cerebral oxygenation in brain dysfunction of acute-on-chronic liver failure patients.
    Sawhney R; Holland-Fischer P; Rosselli M; Mookerjee RP; Agarwal B; Jalan R
    Liver Transpl; 2016 Jun; 22(6):732-42. PubMed ID: 27028317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum ammonia is a strong prognostic factor for patients with acute-on-chronic liver failure.
    Hu C; Huang K; Zhao L; Zhang F; Wu Z; Li L
    Sci Rep; 2020 Oct; 10(1):16970. PubMed ID: 33046732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic assessments of hepatic encephalopathy and ammonia levels predict mortality in acute-on-chronic liver failure.
    Verma N; Dhiman RK; Choudhury A; Taneja S; Duseja A; Singh V; Al Mahtab M; Devarbhavi H; Shukla A; Ning Q; Hamid SS; Butt AS; Jafri W; Tan SS; Hu J; Zhongping D; Treeprasertsuk S; Lee GH; Ghazinyan H; Lesmana LA; Sood A; Midha V; Goyal O; Kim DJ; Eapen CE; Goel A; Tao H; Shaojie X; Yuemin N; Dokmeci AK; Sahu M; Singh A; Arora A; Kumar A; Kumar R; Prasad VGM; Shresta A; Sollano J; Payawal DA; Shah S; Rao PN; Kulkarni A; Lau GK; Sarin SK;
    Hepatol Int; 2021 Aug; 15(4):970-982. PubMed ID: 34275111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic encephalopathy in acute-on-chronic liver failure.
    Lee GH
    Hepatol Int; 2015 Oct; 9(4):520-6. PubMed ID: 26016460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF).
    Cordoba J; Ventura-Cots M; Simón-Talero M; Amorós À; Pavesi M; Vilstrup H; Angeli P; Domenicali M; Ginés P; Bernardi M; Arroyo V;
    J Hepatol; 2014 Feb; 60(2):275-81. PubMed ID: 24128414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast growth factor 21 is an early predictor of acute-on-chronic liver failure in critically ill patients with cirrhosis.
    Ruiz-Margáin A; Pohlmann A; Ryan P; Schierwagen R; Chi-Cervera LA; Jansen C; Mendez-Guerrero O; Flores-García NC; Lehmann J; Torre A; Macías-Rodríguez RU; Trebicka J
    Liver Transpl; 2018 May; 24(5):595-605. PubMed ID: 29476704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical profile, natural history, and predictors of mortality in patients with acute-on-chronic liver failure (ACLF).
    Mikolasevic I; Milic S; Radic M; Orlic L; Bagic Z; Stimac D
    Wien Klin Wochenschr; 2015 Apr; 127(7-8):283-9. PubMed ID: 25821053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebral oedema is rare in acute-on-chronic liver failure patients presenting with high-grade hepatic encephalopathy.
    Joshi D; O'Grady J; Patel A; Shawcross D; Connor S; Deasy N; Willars C; Bernal W; Wendon J; Auzinger G
    Liver Int; 2014 Mar; 34(3):362-6. PubMed ID: 23844567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The intensive care unit course and outcome in acute-on-chronic liver failure are comparable to other populations.
    Meersseman P; Langouche L; du Plessis J; Korf H; Mekeirele M; Laleman W; Nevens F; Wilmer A; Van den Berghe G; van der Merwe SW
    J Hepatol; 2018 Oct; 69(4):803-809. PubMed ID: 29730473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arterial ammonia and clinical risk factors for encephalopathy and intracranial hypertension in acute liver failure.
    Bernal W; Hall C; Karvellas CJ; Auzinger G; Sizer E; Wendon J
    Hepatology; 2007 Dec; 46(6):1844-52. PubMed ID: 17685471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell death markers in patients with cirrhosis and acute decompensation.
    Macdonald S; Andreola F; Bachtiger P; Amoros A; Pavesi M; Mookerjee R; Zheng YB; Gronbaek H; Gerbes AL; Sola E; Caraceni P; Moreau R; Gines P; Arroyo V; Jalan R
    Hepatology; 2018 Mar; 67(3):989-1002. PubMed ID: 29023872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ammonia predicts poor outcomes in patients with hepatitis B virus-related acute-on-chronic liver failure.
    Zhang J; Liu X; Ye B; Chen H
    J Clin Lab Anal; 2020 Dec; 34(12):e23553. PubMed ID: 32914901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with non-selective beta blockers is associated with reduced severity of systemic inflammation and improved survival of patients with acute-on-chronic liver failure.
    Mookerjee RP; Pavesi M; Thomsen KL; Mehta G; Macnaughtan J; Bendtsen F; Coenraad M; Sperl J; Gines P; Moreau R; Arroyo V; Jalan R;
    J Hepatol; 2016 Mar; 64(3):574-82. PubMed ID: 26519600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between tumor necrosis factor-alpha and ammonia in patients with hepatic encephalopathy due to chronic liver failure.
    Odeh M; Sabo E; Srugo I; Oliven A
    Ann Med; 2005; 37(8):603-12. PubMed ID: 16338762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modification in CSF specific gravity in acutely decompensated cirrhosis and acute on chronic liver failure independent of encephalopathy, evidences for an early blood-CSF barrier dysfunction in cirrhosis.
    Weiss N; Rosselli M; Mouri S; Galanaud D; Puybasset L; Agarwal B; Thabut D; Jalan R
    Metab Brain Dis; 2017 Apr; 32(2):369-376. PubMed ID: 27730496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased delayed mortality in patients with acute-on-chronic liver failure who have prior decompensation.
    Shi Y; Zheng MH; Yang Y; Wei W; Yang Q; Hu A; Hu Y; Wu Y; Yan H
    J Gastroenterol Hepatol; 2015 Apr; 30(4):712-8. PubMed ID: 25250673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic inflammation is associated with increased intrahepatic resistance and mortality in alcohol-related acute-on-chronic liver failure.
    Mehta G; Mookerjee RP; Sharma V; Jalan R
    Liver Int; 2015 Mar; 35(3):724-34. PubMed ID: 24703488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune dysfunction in cirrhosis: Distinct cytokines phenotypes according to cirrhosis severity.
    Dirchwolf M; Podhorzer A; Marino M; Shulman C; Cartier M; Zunino M; Paz S; Muñoz A; Bocassi A; Gimenez J; Di Pietro L; Romero G; Fainboim H; Fainboim L
    Cytokine; 2016 Jan; 77():14-25. PubMed ID: 26517154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyponatremia influences the outcome of patients with acute-on-chronic liver failure: an analysis of the CANONIC study.
    Cárdenas A; Solà E; Rodríguez E; Barreto R; Graupera I; Pavesi M; Saliba F; Welzel TM; Martinez-Gonzalez J; Gustot T; Bernardi M; Arroyo V; Ginès P;
    Crit Care; 2014 Dec; 18(6):700. PubMed ID: 25643318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human beta-defensin-1 is a highly predictive marker of mortality in patients with acute-on-chronic liver failure.
    Mani I; Alexopoulou A; Vasilieva L; Hadziyannis E; Agiasotelli D; Bei M; Alexopoulos T; Dourakis SP
    Liver Int; 2019 Feb; 39(2):299-306. PubMed ID: 30261128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.